STOCK TITAN

DNOW Inc. Form 4 Filings

DNOW NYSE

Every Form 4 that DNOW Inc. (DNOW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DNOW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DNOW filings page.

Rhea-AI Summary

DNOW Inc. officer Raymond W. Chang, VP and General Counsel, reported an option exercise-and-sale sequence in DNOW common stock on 2026-08-10. He exercised 43,621 non-qualified stock options at an exercise price of $9.53 per share and 32,617 options at $10.26 per share, receiving the same number of DNOW common shares. He then sold 43,621 and 32,617 common shares, respectively, at a sale price of $16.98 per share. The filing’s Rule 10b5-1 checkbox is unchecked, and no post-transaction share holdings are reported in this form.

Rhea-AI Summary

DNOW Inc. President and CEO David A. Cherechinsky exercised stock options for 256,142 shares of common stock on August 10, 2026, at exercise prices of $9.53 and $10.26 per share, and sold the same total number of shares at $16.73 per share in open-market or private transactions. The options referenced in the filing vest in three equal installments, and the transactions were not reported as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

DNOW Inc. executive Mark B. Johnson, Senior Vice President and Chief Financial Officer, reported option exercises and related stock sales. On 2026-08-10 he exercised 72,166 Non-Qualified Stock Options for common stock at $9.53 and $10.26 per share, then sold 112,841 common shares at $16.79 per share in open-market or private transactions.

Rhea-AI Summary

ALARIO RICHARD J reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director Richard J. Alario reported receiving a grant of 17,122 shares of common stock on May 20, 2026. The shares were awarded at a reported price of $0.00 per share, indicating a compensation-related grant rather than a market purchase. Following this award, Alario directly holds 294,169 shares of DNOW common stock, so the grant represents a relatively small addition to his existing position.

Rhea-AI Summary

JADIN RONALD L reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director Ronald L. Jadin received a stock award of 12,122 shares of common stock on May 20, 2026. The award was reported at a price of $0.00 per share, indicating it was a compensation grant rather than a market purchase. Following this grant, his direct ownership increased to 66,341 common shares.

Rhea-AI Summary

Bonno Terry reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director Terry Bonno received a stock award of 12,122 shares of common stock on May 20, 2026. The award was recorded at a price of $0.00 per share, indicating it was compensation rather than an open-market purchase. Following this grant, Bonno directly holds 124,994 DNOW common shares.

Rhea-AI Summary

DNOW Inc. director Paul M. Coppinger received a grant of 12,122 shares of common stock on May 20, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related stock award rather than a market purchase.

After this grant, Coppinger directly owns 78,846 shares of DNOW common stock. The filing does not show any sales or option exercises, only this stock award that increases his direct equity stake.

Rhea-AI Summary

David-Green Karen reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director Karen David-Green received a stock grant of 12,122 shares of common stock, recorded at no cash price per share. After this award, she directly holds a total of 43,956 DNOW common shares, reflecting a routine compensation-related equity grant rather than an open‑market purchase or sale.

Rhea-AI Summary

Cobb Galen reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director Galen Cobb received a stock award of 12,122 shares of common stock as compensation, rather than buying them in the market. The award was granted at no cash cost per share. After this grant, Cobb directly holds a total of 122,594 DNOW common shares.

Rhea-AI Summary

DNOW Inc. director George John Damiris received a grant of 12,122 shares of common stock, recorded at a price of $0.00 per share, as a non-cash award. This compensation-related acquisition increased his direct holdings to 66,341 shares of DNOW common stock.

Rhea-AI Summary

Reed Sonya reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director Sonya Reed received a stock grant. On May 20, 2026, she was awarded 12,122 shares of DNOW common stock at no cost as a compensation-related grant. Following this award, she directly holds 70,360 shares of DNOW common stock. This is a non-market transaction and does not reflect an open-market purchase or sale.

Rhea-AI Summary

DNOW Inc. VP and Chief Accounting Officer Gillian Anderson reported a disposition of 834 shares of common stock at $11.29 per share on March 12, 2026. The shares were withheld from the vesting of restricted stock to cover tax obligations, and she now directly holds 69,597 shares.

Rhea-AI Summary

DNOW Inc. reported that its VP and General Counsel, Raymond W. Chang, acquired 40,242 shares of common stock through a grant or award on 2026-02-23. The shares were awarded at a stated price of $0.0000 per share, bringing his directly owned stake to 360,388 common shares.

Rhea-AI Summary

Johnson Mark B reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. reported that officer Mark B. Johnson received a grant of 61,674 shares of common stock on February 23, 2026, at no per-share cost as a stock award. Following this grant, his directly held ownership increased to 290,220 common shares.

Rhea-AI Summary

Munson Kelly T. reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. officer Kelly T. Munson received a grant of 28,823 shares of common stock on February 23, 2026. This was recorded as a share award with no purchase price. After the grant, Munson directly held 172,085 common shares, plus 156 shares held indirectly through a 401(k) account.

Rhea-AI Summary

DNOW Inc. reported that VP and Chief Accounting Officer Gillian Anderson received an equity award of 18,726 shares of common stock. The shares were acquired at a reported price of $0.00 per share as a grant or award, not as an open-market purchase. Following this transaction, Anderson directly owns 70,431 shares of DNOW common stock.

Rhea-AI Summary

Cherechinsky David A reported acquisition or exercise transactions in this Form 4 filing.

DNOW Inc. director and President and CEO David A. Cherechinsky received an equity grant of 203,603 shares of common stock on 2026-02-23. The award was reported at a price of $0.0000 per share, reflecting a grant or award rather than an open-market purchase. Following this grant, his directly owned common stock holdings totaled 1,163,864 shares.

Rhea-AI Summary

DNOW Inc. director and officer David A. Cherechinsky reported equity-related transactions in common stock tied to restricted and performance share awards. On February 20, 2026, he disposed of 52,558 shares and 35,414 shares at $13.23 per share through tax-withholding dispositions related to vesting awards. He also acquired 89,995 shares for no cash consideration upon satisfaction of performance criteria under a performance share award. After these transactions, his directly held common stock positions reported in the filing increased compared with the prior award vesting, reflecting the net impact of award settlement and related tax withholding.

Rhea-AI Summary

DNOW Inc. officer Mark B. Johnson reported equity compensation activity in common stock. He received a grant or award of 20,999 shares for no cash consideration upon satisfaction of performance criteria. To cover tax withholding on vesting of restricted and performance shares, 12,264 shares and 8,264 shares were disposed of at $13.23 per share through share withholding, a non‑open‑market method. Following these transactions, he directly owned 228,546 common shares.

Rhea-AI Summary

DNOW Inc. officer Raymond W. Chang reported equity compensation activity in company common stock. He received a grant of 20,999 shares at no cost upon satisfaction of performance criteria, while 12,533 and 8,264 shares were withheld to cover tax liabilities on vesting of restricted and performance shares.

Rhea-AI Summary

DNOW Inc. officer Kelly T. Munson reported equity-compensation related transactions in DNOW common stock. On February 20, 2026, Munson received 15,000 shares at $0.0000 per share as a grant upon satisfaction of performance criteria, increasing directly held stock. On the same date, DNOW withheld 8,760 shares and 5,903 shares at $13.23 per share from vesting restricted and performance awards to cover tax liabilities. After these transactions, Munson directly owned 143,262 DNOW shares, with an additional 156 shares held indirectly through a 401(k) plan.

Rhea-AI Summary

DNOW Inc. executive reports tax-related share withholding and updated equity holdings. VP and Chief Accounting Officer Gillian Anderson had 1,247 shares of common stock withheld on February 7, 2026, coded as an "F" transaction, at a price of $16.76 per share to cover tax obligations from restricted stock vesting.

After this withholding, Anderson beneficially owns 51,705 shares of DNOW common stock, held directly. This total includes 19,971 restricted stock units received in connection with the closing of a merger involving DNOW and MRC Global Inc. These RSUs vest in two tranches, with 12,864 vesting on February 7, 2027 and 7,107 vesting on March 12, 2028, contingent on continued service and subject to possible accelerated vesting in certain circumstances.